{"entity":{"id":"1966","kind":"year","name":"1966 in oncology","aka":["1966"],"tldr":"Everything OnCo dates to 1966: 11 entries, 5 landmarks, 2 approvals, 2 journals founded and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"11 dated entries in OnCo fall in 1966: 5 landmarks, 2 approvals, 2 journals founded, 1 company founded and 1 paper listed on a person's page.\n\nOf those, 11 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1965","1967"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1966,"events":[{"group":"approval","date":"1966","precision":"year","title":"Pipobroman approved in US","note":"Polycythaemia vera; chronic myeloid leukaemia refractory to busulfan (historic label). Discontinued","from":"pipobroman","refs":[]},{"group":"approval","date":"1966","precision":"year","title":"Thioguanine approved in US","note":"Remission induction and consolidation of acute non-lymphocytic leukaemias","from":"thioguanine","refs":[]},{"group":"company","date":"1966","precision":"year","title":"Serum Institute of India founded","note":"Pune","from":"serum-institute-of-india","refs":[]},{"group":"history","date":"1966","precision":"year","title":"EBV antibodies linked to NPC (Old et al.)","note":"Nasopharyngeal carcinoma","from":"nasopharyngeal","refs":[]},{"group":"history","date":"1966","precision":"year","title":"Gleason describes his grading system","note":"Localised prostate cancer, very low and low risk","from":"prostate-low-risk","refs":["gleason-grade-group"]},{"group":"history","date":"1966","precision":"year","title":"Gleason grading system published","note":"Prostate cancer","from":"prostate","refs":["gleason-grade-group"]},{"group":"history","date":"1966","precision":"year","title":"Lukes and Butler define lymphocyte-predominant Hodgkin disease","note":"Nodular lymphocyte-predominant Hodgkin lymphoma (nodular lymphocyte-predominant B-cell lymphoma)","from":"nodular-lymphocyte-predominant-hodgkin-lymphoma","refs":[]},{"group":"history","date":"1966","precision":"year","title":"Old and colleagues link Epstein-Barr virus to nasopharyngeal carcinoma","note":"Locoregionally advanced nasopharyngeal carcinoma (stage III to IVA)","from":"locoregionally-advanced-nasopharyngeal-carcinoma","refs":["ebv-term"]},{"group":"journal","date":"1966","precision":"year","title":"Bulletin du cancer founded","note":"Elsevier Masson","from":"bulletin-du-cancer","refs":[]},{"group":"journal","date":"1966","precision":"year","title":"International journal of cancer founded","note":"Wiley","from":"international-journal-of-cancer","refs":[]},{"group":"person-paper","date":"1966","precision":"year","title":"Chemotherapy in the Treatment of Leukemia and Wilms' Tumor","note":"JAMA: The Journal of the American Medical Association","from":"sidney-farber","refs":[]}]},"route":"/years/1966/","neighbours":{"year":[{"id":"1965","kind":"year","name":"1965 in oncology","route":"/years/1965/"},{"id":"1967","kind":"year","name":"1967 in oncology","route":"/years/1967/"}]}}